Related Experiment Video
Updated: Sep 14, 2026

Polygraphic Recording Procedure for Measuring Sleep in Mice
Published on: January 26, 2016
Inhibition of prostaglandin synthesis reduces hyperthermic reactions induced by hypocretin-1/orexin A
M Monda1, A Viggiano, P Mondola
1Department of Experimental Medicine, Section of Human Physiology, Second University of Naples, via Costantinopoli 16, 80138, Naples, Italy. marcellino.monda@unina2.it
Abstract:
This experiment tested (i) the effect of orexin A injected into a lateral cerebral ventricle on sympathetic and thermogenic activity and (ii) the involvement of prostaglandins in these phenomena. The firing rates of the sympathetic nerves to interscapular brown adipose tissue (IBAT), along with IBAT and colonic temperatures and heart rate were monitored in urethane-anesthetized male Sprague-Dawley rats before and 6 h after an injection of orexin A (1.5 nmol) into the lateral cerebral ventricle. The same variables were monitored in rats with an intraperitoneal administration of lysine acetylsalicylate (100 mg/kg bw), an inhibitor of prostaglandins synthesis. The results show that orexin A increases the sympathetic firing rate, IBAT and colonic temperatures and heart rate. This increase is reduced by lysine acetylsalicylate. These findings suggest that orexin A affects sympathetic activity, which controls body temperature. Prostaglandins are involved in this control.
Related Concept Videos
Feedback Inhibition
GPCRs Regulate Adenylyl Cylase Activity
Two...
Desensitization and Tachyphylaxis
Several...
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

